- Home
- AMBI vs LYEL Comparison
AMBI vs LYEL Comparison
Compare AMBI & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBI
- LYEL
- Stock Information
- Founded
- AMBI 1995
- LYEL 2018
- Country
- AMBI Brazil
- LYEL United States
- Employees
- AMBI N/A
- LYEL N/A
- Industry
- AMBI Environmental Services
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- AMBI Industrials
- LYEL Health Care
- Exchange
- AMBI Nasdaq
- LYEL Nasdaq
- Market Cap
- AMBI 242.5M
- LYEL 207.7M
- IPO Year
- AMBI N/A
- LYEL 2021
- Fundamental
- Price
- AMBI $4.06
- LYEL $0.44
- Analyst Decision
- AMBI
- LYEL Sell
- Analyst Count
- AMBI 0
- LYEL 2
- Target Price
- AMBI N/A
- LYEL $1.00
- AVG Volume (30 Days)
- AMBI 6.0K
- LYEL 627.4K
- Earning Date
- AMBI 01-01-0001
- LYEL 05-13-2025
- Dividend Yield
- AMBI N/A
- LYEL N/A
- EPS Growth
- AMBI N/A
- LYEL N/A
- EPS
- AMBI N/A
- LYEL N/A
- Revenue
- AMBI $532,477,487.00
- LYEL $65,000.00
- Revenue This Year
- AMBI N/A
- LYEL N/A
- Revenue Next Year
- AMBI N/A
- LYEL N/A
- P/E Ratio
- AMBI N/A
- LYEL N/A
- Revenue Growth
- AMBI 27.16
- LYEL N/A
- 52 Week Low
- AMBI $3.22
- LYEL $0.39
- 52 Week High
- AMBI $8.20
- LYEL $2.80
- Technical
- Relative Strength Index (RSI)
- AMBI 41.99
- LYEL 51.63
- Support Level
- AMBI $4.25
- LYEL $0.39
- Resistance Level
- AMBI $5.06
- LYEL $0.43
- Average True Range (ATR)
- AMBI 0.38
- LYEL 0.03
- MACD
- AMBI -0.03
- LYEL 0.00
- Stochastic Oscillator
- AMBI 0.00
- LYEL 83.39
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.